InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Trigilio Jeffrey, Chief Financial Officer. Director active across 1 companies, notably Cullinan Oncology, Inc.. In total, 5 filings have been logged. The latest transaction was disclosed on 11 February 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations5 total
037,500 shares0
Common Stock
SEC:0000899243-22-006412:0·
€29,6778,000 shares@ €3.70960.0031% mcap35.2% of flow
Common Stock
SEC:0000899243-21-040454·
€29,6778,000 shares@ €3.70960.0031% mcap17.6% of flow
Common Stock
SEC:0000899243-21-040454:0·
€54,57315,000 shares@ €3.63820.0056% mcap64.8% of flow
Common Stock
SEC:0000899243-21-035417·
€54,57315,000 shares@ €3.63820.0056% mcap32.4% of flow
Common Stock
SEC:0000899243-21-035417:0·
5 of 5 declarations
About Trigilio Jeffrey
Jeffrey Trigilio is the Chief Financial Officer at Cullinan Oncology, Inc. He is responsible for the financial management of the company, including financial planning, analysis, and risk management. With a strong background in the healthcare sector, he plays a key role in developing financial strategies that support the company's mission to develop innovative cancer treatments.
